Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel 17beta-HSD inhibitors designed by Sterix

Nov. 23, 2004

European orphan drug designation for Aplidin for multiple myeloma

Nov. 23, 2004

New European study for TheraCIM in pancreatic cancer

Nov. 23, 2004

Tarceva approved for advanced NSCLC

Nov. 22, 2004

Update on the antitumor efficacy and safety of BAY-43-9006

Nov. 22, 2004

Raf-kinase inhibitors in early development at Merck

Nov. 22, 2004

New protein kinase inhibitors prepared and tested at Roche

Nov. 22, 2004

Roche researchers describe receptor tyrosine kinase inhibitors

Nov. 22, 2004

Dosing commences in phase I study of LEraf-AON

Nov. 22, 2004

New NCI-sponsored study of GTI-2040 for prostate cancer

Nov. 22, 2004

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...